The molecular basis of antimalarial drug resistance in Plasmodium vivax.

Buyon, Lucas E; Elsworth, Brendan; Duraisingh, Manoj T

Buyon, Lucas E; Elsworth, Brendan; Duraisingh, Manoj T.

Buyon LE; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, 02115, MA, USA.
Elsworth B; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, 02115, MA, USA.
Duraisingh MT; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, 02115, MA, USA. Electronic address: mduraisi@hsph.harvard.edu.

Int J Parasitol Drugs Drug Resist ; 16: 23-37, 2021 08.

Article en En | MEDLINE | ID: mdl-33957488

Asunto(s)

Antimaláricos; Malaria Vivax; Antimaláricos/farmacología; Antimaláricos/uso terapéutico; Cloroquina/farmacología; Cloroquina/uso terapéutico; Resistencia a Medicamentos/genética; Humanos; Malaria Vivax/tratamiento farmacológico; Plasmodium vivax/genética

Palabras clave

Drug resistance; Plasmodium vivax. Malaria

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Vivax / Antimaláricos Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Vivax / Antimaláricos Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article